holyflox 5 mg/ml soluţie perfuzabilă
holyhead pharmaceuticals private ltd., - levofloxacinum - soluţie perfuzabilă - 5 mg/ml
azimac 200 mg/5 ml pulbere pentru suspensie orală
gm pharmaceuticals ltd. - azithromycinum - pulbere pentru suspensie orală - 200 mg/5 ml
antacid comprimate 500 mg
eurofarmaco sa, ics - calciu carbonas - comprimate - 500 mg
levofloxacină 5 mg ml 5 mg/ml soluţie perfuzabilă
ncpc international corp. - levofloxacinum - soluţie perfuzabilă - 5 mg/ml
drotaverina solutie injectabila 20 mg/ml
balkan pharmaceuticals srl, sc - drotaverinum - solutie injectabila - 20 mg/ml
dibazol solutie injectabila 1%
farmaco sa, im - bendazolum - solutie injectabila - 1%
drotaverin clorhidrat comprimate 40 mg
upm din borisov sad - drotaverinum - comprimate - 40 mg
pimetafen supozitoare 1000 mg + 10 mg + 0,1 mg
farmaprim srl - metamizoli de sodiu + pitofenonum + fenpiverini bromidum - supozitoare - 1000 mg + 10 mg + 0,1 mg
atropin sulfat solutie injectabila 1 mg/ml
gntls srl, uzina experimentala - atropini sulfas - solutie injectabila - 1 mg/ml
alunbrig
takeda pharma a/s - brigatinib - carcinom, pulmonar non-celulă mică - agenți antineoplazici - alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase alkpositive advanced nsclc previously treated with crizotinib.